DrJorgeB_George (@drjorgebarriuso) 's Twitter Profile Photo

Thank you ESMO - Eur. Oncology #ESMOGI2025 chairs & organizing committee to bring GI #rarecancers to the stage and having me in good company. I hope I brought some awareness to #appendixcancers #pseudomyxoma #peritonealmesothelioma #ESMOAmbassadors Asociación Peritoneum Appendix Cancer PMP Research Foundation Hospital Universitario 12 de Octubre

Thank you <a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMOGI2025 chairs &amp; organizing committee to bring GI #rarecancers to the stage and having me in good company. I hope I brought some awareness to #appendixcancers #pseudomyxoma #peritonealmesothelioma
#ESMOAmbassadors 
<a href="/APeritoneum/">Asociación Peritoneum</a> <a href="/acpmpresearch/">Appendix Cancer PMP Research Foundation</a> <a href="/H12Octubre/">Hospital Universitario 12 de Octubre</a>
Dr. Cathy Eng (@cathyengmd) 's Twitter Profile Photo

The best way to close out ESMO - Eur. Oncology meeting after lectures is sharing time with colleagues MD Anderson Cancer Center. I may be working at Vanderbilt University Medical Center now but we are friends forever! 🙏🏻 Arvind Dasari, MD, MS Drs. M Overman and Alda Tam. #ESMOGI25 #ESMOAmbassadors #cancer #CancerResearch

The best way to close out <a href="/myESMO/">ESMO - Eur. Oncology</a> meeting after lectures is sharing time with colleagues <a href="/MDAndersonNews/">MD Anderson Cancer Center</a>.  I may be working at <a href="/VUMCDiscoveries/">Vanderbilt University Medical Center</a> now but we are friends forever!  🙏🏻 <a href="/adasarimd/">Arvind Dasari, MD, MS</a> Drs. M Overman and Alda Tam.  #ESMOGI25 #ESMOAmbassadors #cancer #CancerResearch
Angela Lamarca (@drangelalamarca) 's Twitter Profile Photo

Bye bye Barcelona, very busy but very fruitful ESMO - Eur. Oncology #ESMOGI25 Full of science, networking and colleagues that are becoming a second family #ESMOGI26 📍Munich 🗓️1-4 July 2026 #ESMOAmbassadors

Bye bye Barcelona, very busy but very fruitful <a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMOGI25

Full of science, networking and colleagues that are becoming a second family

#ESMOGI26
📍Munich
🗓️1-4 July 2026

#ESMOAmbassadors
Angela Lamarca (@drangelalamarca) 's Twitter Profile Photo

Results from EORTC EORTC-1607 / ABC-09 presented at ESMO - Eur. Oncology #ESMOGI25 Advanced BTC First-line CisGem+Pembro Phase II - Biomarker discovery 📸 Full details ⬆️CPS - longer PFS ⬆️CD8/Treg - responders ⬇️PD-L1+CD4, PD-L1+CD8 on treatment (regardless of response) #ESMOAmbassadors

Results from <a href="/EORTC/">EORTC</a> EORTC-1607 / ABC-09 presented at <a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMOGI25

Advanced BTC
First-line CisGem+Pembro 
Phase II - Biomarker discovery

📸 Full details
⬆️CPS - longer PFS
⬆️CD8/Treg - responders
⬇️PD-L1+CD4, PD-L1+CD8 on treatment (regardless of response)

#ESMOAmbassadors
Angela Lamarca (@drangelalamarca) 's Twitter Profile Photo

My selection of posters for #PDAC from ESMO - Eur. Oncology #ESMOGI25 👉Understanding the impact of some of the molecular alterations identified in outcome - important to put into context some of the emerging data: KRAS, CDKN2A, Claudine 👉Novel IO strategies coming #ESMOAmbassadors

My selection of posters for #PDAC from <a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMOGI25

👉Understanding the impact of some of the molecular alterations identified in outcome - important to put into context some of the emerging data: KRAS, CDKN2A, Claudine

👉Novel IO strategies coming

#ESMOAmbassadors
Angela Lamarca (@drangelalamarca) 's Twitter Profile Photo

The relevance of a WIDE molecular profiling in #PDAC and #BiliaryMalignancies Our data from Fundación Jiménez Díaz presented at ESMO - Eur. Oncology #ESMOGI25 👉Targets in PDAC are identified when wide pannels are used-regardless of KRAS 🧬MTAP loss present both in PDAC and BTC #ESMOAmbassadors

The relevance of a WIDE molecular profiling in #PDAC and #BiliaryMalignancies

Our data from <a href="/Hospital_FJD/">Fundación Jiménez Díaz</a> presented at <a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMOGI25

👉Targets in PDAC are identified when wide pannels are used-regardless of KRAS
🧬MTAP loss present both in PDAC and BTC

#ESMOAmbassadors
Angela Lamarca (@drangelalamarca) 's Twitter Profile Photo

My selection of the highlights in hepato-pancreato-biliary from ESMO - Eur. Oncology #ESMOGI25 summarised by Teresa Macarulla 🤖PANOVA3 - QoL with TTFields in PDAC 🫷TALENTACE - Intermediate stage HCC 🎯Inpagratinib - FGF19 +ve HCC 🧬Olaparib in HRD BTC #ESMOAmbassadors

My selection of the highlights in hepato-pancreato-biliary from <a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMOGI25 summarised by <a href="/MacarullaTeresa/">Teresa Macarulla</a> 

🤖PANOVA3 - QoL with TTFields in PDAC
🫷TALENTACE - Intermediate stage HCC
🎯Inpagratinib - FGF19 +ve HCC
🧬Olaparib in HRD BTC

#ESMOAmbassadors
Angela Lamarca (@drangelalamarca) 's Twitter Profile Photo

Closing remarks at ESMO - Eur. Oncology #ESMOGI25 Take home messages by #MichelDucreux on #ESMOGuidelines 🧐Large portfolio 🏃🏻‍♀️Living guidelines 🗣️Slide decs available 🌏PAGA: towards global guidelines 😊Feedback always welcome Full info: esmo.org/guidelines #ESMOAmbassadors

Closing remarks at <a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMOGI25

Take home messages by #MichelDucreux on #ESMOGuidelines

🧐Large portfolio
🏃🏻‍♀️Living guidelines
🗣️Slide decs available
🌏PAGA: towards global guidelines
😊Feedback always welcome

Full info: esmo.org/guidelines

#ESMOAmbassadors
Angela Lamarca (@drangelalamarca) 's Twitter Profile Photo

Closing remarks at ESMO - Eur. Oncology #ESMOGI25 Patient perspective lecture by #Dice Many steps to improve 👉Early diagnosis- let’s be proactive 👀Early on-set 🤝Decision making beyond signing informed consent 🫂Communication - what, how, when matters #ESMOAmbassadors

Closing remarks at <a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMOGI25

Patient perspective lecture by #Dice

Many steps to improve
👉Early diagnosis- let’s be proactive
👀Early on-set 
🤝Decision making beyond signing informed consent
🫂Communication - what, how, when matters

#ESMOAmbassadors
Lorenza Rimassa (@lorenzarimassa) 's Twitter Profile Photo

Promising results of olaparib as a potential new #PrecisionOncology treatment for patients with biliary tract cancer #BTC #CCA and aberrant #HRR mutations. #ESMOGI25 #ESMOAmbassadors ESMO - Eur. Oncology